HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Decree Sends SciLabs To Supplement Manufacturing Sideline

This article was originally published in The Tan Sheet

Executive Summary

The Irvine, Calif., firm, which makes supplements distributed under the brand All Pro Science, and CEO Paul Edalat in federal court entered a consent decree of permanent injunction with FDA and DoJ to prevent the distribution of adulterated supplements.

You may also be interested in...



More Criminal Cases Likely In Supplement, Food Safety, DoJ Official Says

The Obama administration supports pressing criminal charges in cases of contaminated or adulterated supplements or food products, and the Department of Justice is “working closely” with FDA’s food safety center, says DoJ Consumer Protection Branch official Jeffrey Steger.

New EU Approvals

The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add five new products, including Enjaymo, Sanofi’s treatment for hemolytic anemia in adult patients with cold agglutinin disease.

Saudi FDA Finalizes Approach To Commercial Info In Public Assessment Reports

Saudi Arabia has explained what information on a drug’s review will be made public following a marketing authorization decision. 

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS123913

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel